EXHIBIT 10.15

     THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF
     THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
     AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON
     STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED
     FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
     REGISTRATION STATEMENT AS TO THIS WARRANT AND THE COMMON STOCK ISSUABLE
     UPON EXERCISE OF THIS WARRANT UNDER SAID ACT AND ANY APPLICABLE STATE
     SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO AMS
     HEALTH SCIENCES, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

           Right to Purchase up to 2,272,727 Shares of Common Stock of
                            AMS Health Sciences, Inc.
                   (subject to adjustment as provided herein)

                          COMMON STOCK PURCHASE WARRANT

No. _________________                               Issue Date:  June 28, 2006

     AMS Health Sciences, Inc., a corporation organized under the laws of the
State of Oklahoma (the "Company"), hereby certifies that, for value received,
LAURUS MASTER FUND, LTD., or assigns (the "Holder"), is entitled, subject to the
terms set forth below, to purchase from the Company (as defined herein) from and
after the Issue Date of this Warrant and at any time or from time to time before
5:00 p.m., New York time, through the close of business June 28, 2011 (the
"Expiration Date"), up to 2,272,727 fully paid and nonassessable shares of
Common Stock (as hereinafter defined), $0.0001 par value per share, at the
applicable Exercise Price per share (as defined below). The number and character
of such shares of Common Stock and the applicable Exercise Price per share are
subject to adjustment as provided herein.

     As used herein the following terms, unless the context otherwise requires,
have the following respective meanings:

     (a)  The term "Company" shall include AMS Health Sciences, Inc. and any
          person or entity which shall succeed, or assume the obligations of,
          AMS Health Sciences, Inc. hereunder.

     (b)  The term "Common Stock" includes (i) the Company's Common Stock, par
          value $0.0001 per share; and (ii) any other securities into which or
          for which any of the securities described in the preceding clause (i)
          may be converted or exchanged pursuant to a plan of recapitalization,
          reorganization, merger, sale of assets or otherwise.

     (c)  The term "Other Securities" refers to any stock (other than Common
          Stock) and other securities of the Company or any other person
          (corporate or otherwise) which the holder of the Warrant at any time
          shall be entitled to receive, or shall have received, on the exercise
          of the Warrant, in lieu of or in addition to Common Stock, or which at
          any time shall be issuable or shall have been issued in exchange for
          or in replacement of Common Stock or Other Securities pursuant to
          Section 4 or otherwise.

     (d)  The "Exercise Price" applicable under this Warrant shall be as
          follows: (i) a price of $0.53;

     1. Exercise of Warrant.

          1.1. Number of Shares Issuable upon Exercise. From and after the date
     hereof through and including the Expiration Date, the Holder shall be
     entitled to receive, upon exercise of this Warrant in whole or in part, by
     delivery of an original or fax copy of an exercise notice in the form
     attached hereto as Exhibit A (the "Exercise Notice"), shares of Common
     Stock of the Company, subject to adjustment pursuant to Section 4.

          1.2. Company Acknowledgment. The Company will, at the time of the
     exercise of this Warrant, upon the request of the holder hereof acknowledge
     in writing its continuing obligation to afford to such holder any rights to
     which such holder shall continue to be entitled after such exercise in
     accordance with the provisions of this Warrant. If the holder shall fail to
     make any such request, such failure shall not affect the continuing
     obligation of the Company to afford to such holder any such rights.

          1.3. Trustee for Warrant Holders. In the event that a bank or trust
     company shall have been appointed as trustee for the holders of this
     Warrant pursuant to Subsection 3.2, such bank or trust company shall have
     all the powers and duties of a warrant agent (as hereinafter described) and
     shall accept, in its own name for the account of the Company or such
     successor person as may be entitled thereto, all amounts otherwise payable
     to the Company or such successor, as the case may be, on exercise of this
     Warrant pursuant to this Section 1.

     2. Procedure for Exercise.

          2.1. Delivery of Stock Certificates, Etc., on Exercise. The Company
     agrees that the shares of Common Stock purchased upon exercise of this
     Warrant shall be deemed to be issued to the Holder as the record owner of
     such shares as of the close of business on the date on which this Warrant
     shall have been surrendered and payment made for such shares in accordance
     herewith. As soon as practicable after the exercise of this Warrant in full
     or in part, and in any event within three (3) business days thereafter, the
     Company at its expense (including the payment by it of any applicable issue
     taxes) will cause to be issued in the name of and delivered to the Holder,
     or as such Holder (upon payment by such Holder of any applicable transfer
     taxes) may direct in compliance with applicable securities laws, a
     certificate or certificates for the number of duly and validly issued,
     fully paid and nonassessable shares of Common Stock (or Other Securities)
     to which such Holder shall be entitled on such exercise.,

          2.2. Exercise. (a) Payment may be made in cash or by certified or
     official bank check payable to the order of the Company equal to the
     applicable aggregate Exercise Price for the number of Common Shares
     specified in such Exercise Notice (as such exercise number shall be
     adjusted to reflect any adjustment in the total number of shares of Common
     Stock issuable to the Holder per the terms of this Warrant) and the Holder
     shall thereupon be entitled to receive the number of duly authorized,
     validly issued, fully-paid and non-assessable shares of Common Stock (or
     Other Securities) determined as provided herein.

     3. Effect of Reorganization, Etc.; Adjustment of Exercise Price.

          3.1. Reorganization, Consolidation, Merger, Etc. In case at any time
     or from time to time, the Company shall (a) effect a reorganization, (b)
     consolidate with or merge into any other person, or (c) transfer all or
     substantially all of its properties or assets to any other person under any
     plan or arrangement contemplating the dissolution of the Company, then, in
     each such case, as a condition to the consummation of such a transaction,
     proper and adequate provision shall be made by the Company whereby the
     Holder, on the exercise hereof as provided in Section 1 at any time after
     the consummation of such reorganization, consolidation or merger or the
     effective date of such dissolution, as the case may be, shall receive, in
     lieu of the Common Stock (or Other Securities) issuable on such exercise
     prior to such consummation or such effective date, the stock and other
     securities and property (including cash) to which such Holder would have
     been entitled upon such consummation or in connection with such
     dissolution, as the case may be, if such Holder had so exercised this
     Warrant, immediately prior thereto, all subject to further adjustment
     thereafter as provided in Section 4.

          3.2. Dissolution. In the event of any dissolution of the Company
     following the transfer of all or substantially all of its properties or
     assets, the Company, concurrently with any distributions made to holders of
     its Common Stock, shall at its expense deliver or cause to be delivered to
     the Holder the stock and other securities and property (including cash,
     where applicable) receivable by the Holder pursuant to Section 3.1, or, if
     the Holder shall so instruct the Company, to a bank or trust company
     specified by the Holder and having its principal office in New York, NY as
     trustee for the Holder (the "Trustee").

          3.3. Continuation of Terms. Upon any reorganization, consolidation,
     merger or transfer (and any dissolution following any transfer) referred to
     in this Section 3, this Warrant shall continue in full force and effect and
     the terms hereof shall be applicable to the shares of stock and other
     securities and property receivable on the exercise of this Warrant after
     the consummation of such reorganization, consolidation or merger or the
     effective date of dissolution following any such transfer, as the case may
     be, and shall be binding upon the issuer of any such stock or other
     securities, including, in the case of any such transfer, the person
     acquiring all or substantially all of the properties or assets of the
     Company, whether or not such person shall have expressly assumed the terms
     of this Warrant as provided in Section 4. In the event this Warrant does
     not continue in full force and effect after the consummation of the
     transactions described in this Section 3, then the Company's securities and
     property (including cash, where applicable) receivable by the Holder will
     be delivered to the Holder or the Trustee as contemplated by Section 3.2.

     4. Extraordinary Events Regarding Common Stock. In the event that the
Company shall (a) issue additional shares of the Common Stock as a dividend or
other distribution on outstanding Common Stock or any preferred stock issued by
the Company (b) subdivide its outstanding shares of Common Stock, or (c) combine
its outstanding shares of the Common Stock into a smaller number of shares of
the Common Stock, then, in each such event, the Exercise Price shall,
simultaneously with the happening of such event, be adjusted by multiplying the
then Exercise Price by a fraction, the numerator of which shall be the number of
shares of Common Stock outstanding immediately prior to such event and the
denominator of which shall be the number of shares of Common Stock outstanding
immediately after such event, and the product so obtained shall thereafter be
the Exercise Price then in effect. The Exercise Price, as so adjusted, shall be
readjusted in the same manner upon the happening of any successive event or
events described herein in this Section 4. The number of shares of Common Stock
that the Holder shall thereafter, on the exercise hereof as provided in Section
1, be entitled to receive shall be adjusted to a number determined by
multiplying the number of shares of Common Stock that would otherwise (but for
the provisions of this Section 4) be issuable on such exercise by a fraction of
which (a) the numerator is the Exercise Price that would otherwise (but for the
provisions of this Section 4) be in effect, and (b) the denominator is the
Exercise Price in effect on the date of such exercise (taking into account the
provisions of this Section 4). Notwithstanding the foregoing, in no event shall
the Exercise Price be less than the par value of the Common Stock.

     5. Certificate as to Adjustments. In each case of any adjustment or
readjustment in the shares of Common Stock (or Other Securities) issuable on the
exercise of this Warrant, the Company at its expense will promptly cause its
Chief Financial Officer or other appropriate designee to compute such adjustment
or readjustment in accordance with the terms of this Warrant and prepare a
certificate setting forth such adjustment or readjustment and showing in detail
the facts upon which such adjustment or readjustment is based, including a
statement of (a) the consideration received or receivable by the Company for any
additional shares of Common Stock (or Other Securities) issued or sold or deemed
to have been issued or sold, (b) the number of shares of Common Stock (or Other
Securities) outstanding or deemed to be outstanding, and (c) the Exercise Price
and the number of shares of Common Stock to be received upon exercise of this
Warrant, in effect immediately prior to such adjustment or readjustment and as
adjusted or readjusted as provided in this Warrant. The Company will forthwith
mail a copy of each such certificate to the Holder and any Warrant agent of the
Company (appointed pursuant to Section 11 hereof).

     6. Reservation of Stock, Etc., Issuable on Exercise of Warrant. The Company
will at all times reserve and keep available, solely for issuance and delivery
on the exercise of this Warrant, shares of Common Stock (or Other Securities)
from time to time issuable on the exercise of this Warrant.

     7. Assignment; Exchange of Warrant. Subject to compliance with applicable
securities laws, this Warrant, and the rights evidenced hereby, may be
transferred by any registered holder hereof (a "Transferor") in whole or in
part. On the surrender for exchange of this Warrant, with the Transferor's
endorsement in the form of Exhibit B attached hereto (the "Transferor
Endorsement Form") and together with evidence reasonably satisfactory to the
Company demonstrating compliance with applicable securities laws, which shall
include, without limitation, the provision of a legal opinion from the
Transferor's counsel (at the Company's expense) that such transfer is exempt
from the registration requirements of applicable securities laws, the Company at
its expense (but with payment by the Transferor of any applicable transfer
taxes) will issue and deliver to or on the order of the Transferor thereof a new
Warrant of like tenor, in the name of the Transferor and/or the transferee(s)
specified in such Transferor Endorsement Form (each a "Transferee"), calling in
the aggregate on the face or faces thereof for the number of shares of Common
Stock called for on the face or faces of the Warrant so surrendered by the
Transferor.

     8. Replacement of Warrant. On receipt of evidence reasonably satisfactory
to the Company of the loss, theft, destruction or mutilation of this Warrant
and, in the case of any such loss, theft or destruction of this Warrant, on
delivery of an indemnity agreement or security reasonably satisfactory in form
and amount to the Company or, in the case of any such mutilation, on surrender
and cancellation of this Warrant, the Company at its expense will execute and
deliver, in lieu thereof, a new Warrant of like tenor.

     9. Registration Rights. The Holder has been granted certain registration
rights by the Company. These registration rights are set forth in a Registration
Rights Agreement entered into by the Company and Holder dated as of the date
hereof, as the same may be amended, modified and/or supplemented from time to
time.

     10. Maximum Exercise. Notwithstanding anything herein to the contrary, in
no event shall the Holder be entitled to exercise any portion of this Warrant in
excess of that portion of this Warrant upon exercise of which the sum of (1) the
number of shares of Common Stock beneficially owned by the Holder and its
Affiliates (other than shares of Common Stock which may be deemed beneficially
owned through the ownership of the unexercised portion of the Warrant or the
unexercised or unconverted portion of any other security of the Holder subject
to a limitation on conversion analogous to the limitations contained herein) and
(2) the number of shares of Common Stock issuable upon the exercise of the
portion of this Warrant with respect to which the determination of this proviso
is being made, would result in beneficial ownership by the Holder and its
Affiliates of any amount greater than 4.99% of the then outstanding shares of
Common Stock (whether or not, at the time of such exercise, the Holder and its
Affiliates beneficially own more than 4.99% of the then outstanding shares of
Common Stock). As used herein, the term "Affiliate" means any person or entity
that, directly or indirectly through one or more intermediaries, controls or is
controlled by or is under common control with a person or entity, as such terms
are used in and construed under Rule 144 under the Securities Act. For purposes
of the proviso to the second preceding sentence, beneficial ownership shall be
determined in accordance with Section 13(d) of the Securities Exchange Act of
1934, as amended, and Regulations 13D-G thereunder, except as otherwise provided
in clause (1) of such proviso. The limitations set forth herein (x) may be
waived by the Holder upon provision of no less than sixty-one (61) days prior
notice to the Company and (y) shall automatically become null and void following
notice to the Company upon the occurrence and during the continuance of an Event
of Default (as defined in the Note referred to in the Purchase Agreement dated
as of the date hereof among the Holder and the Company (as amended, modified,
restated and/or supplemented from time to time, the "Purchase Agreement")).

     11. Warrant Agent. The Company may, by written notice to the each Holder of
the Warrant, appoint an agent for the purpose of issuing Common Stock (or Other
Securities) on the exercise of this Warrant pursuant to Section 1, exchanging
this Warrant pursuant to Section 7, and replacing this Warrant pursuant to
Section 8, or any of the foregoing, and thereafter any such issuance, exchange
or replacement, as the case may be, shall be made at such office by such agent.

     12. Transfer on the Company's Books. Until this Warrant is transferred on
the books of the Company, the Company may treat the registered holder hereof as
the absolute owner hereof for all purposes, notwithstanding any notice to the
contrary.

     13. Notices, Etc. All notices and other communications from the Company to
the Holder shall be mailed by first class registered or certified mail, postage
prepaid, at such address as may have been furnished to the Company in writing by
such Holder or, until any such Holder furnishes to the Company an address, then
to, and at the address of, the last Holder who has so furnished an address to
the Company.

     14. Miscellaneous. This Warrant and any term hereof may be changed, waived,
discharged or terminated only by an instrument in writing signed by the party
against which enforcement of such change, waiver, discharge or termination is
sought. THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAWS.
ANY ACTION BROUGHT CONCERNING THE TRANSACTIONS CONTEMPLATED BY THIS WARRANT
SHALL BE BROUGHT ONLY IN THE STATE COURTS OF NEW YORK OR IN THE FEDERAL COURTS
LOCATED IN THE STATE OF NEW YORK; PROVIDED, HOWEVER, THAT THE HOLDER MAY CHOOSE
TO WAIVE THIS PROVISION AND BRING AN ACTION OUTSIDE THE STATE OF NEW YORK. The
individuals executing this Warrant on behalf of the Company agree to submit to
the jurisdiction of such courts and waive trial by jury. The prevailing party
shall be entitled to recover from the other party its reasonable attorneys' fees
and costs. In the event that any provision of this Warrant is invalid or
unenforceable under any applicable statute or rule of law, then such provision
shall be deemed inoperative to the extent that it may conflict therewith and
shall be deemed modified to conform with such statute or rule of law. Any such
provision which may prove invalid or unenforceable under any law shall not
affect the validity or enforceability of any other provision of this Warrant.
The headings in this Warrant are for purposes of reference only, and shall not
limit or otherwise affect any of the terms hereof. The invalidity or
unenforceability of any provision hereof shall in no way affect the validity or
enforceability of any other provision hereof. The Company acknowledges that
legal counsel participated in the preparation of this Warrant and, therefore,
stipulates that the rule of construction that ambiguities are to be resolved
against the drafting party shall not be applied in the interpretation of this
Warrant to favor any party against the other party.

                   [BALANCE OF PAGE INTENTIONALLY LEFT BLANK;
                             SIGNATURE PAGE FOLLOWS]

<PAGE>

     IN WITNESS WHEREOF, the Company has executed this Warrant as of the date
first written above.


                                     AMS HEALTH SCIENCES, INC.

WITNESS:
                                     By:   /s/Jerry W. Grizzle
/s/Robin L. Jacob                    Name:  Jerry W. Grizzle
Robin L. Jacob                       Title: Chairman, President & CEO

<PAGE>

                                    Exhibit A

                              FORM OF SUBSCRIPTION
                   (To Be Signed Only On Exercise Of Warrant)

    TO:  AMS Health Sciences, Inc.

         Attention:        Chief Financial Officer

     The undersigned, pursuant to the provisions set forth in the attached
Warrant (No.____), hereby irrevocably elects to purchase (check applicable box):

_______     ________ shares of the Common Stock covered by such Warrant; or

     The undersigned herewith makes payment of the full Exercise Price for such
shares at the price per share provided for in such Warrant, which is
$___________. Such payment takes the form of (check applicable box or boxes):

_______    $__________ in lawful money of the United States; and/or



     The undersigned requests that the certificates for such shares be issued in
the name of, and delivered to ______________________________________________
whose address is _____________________________________________________________.

     The undersigned represents and warrants that all offers and sales by the
undersigned of the securities issuable upon exercise of the within Warrant shall
be made pursuant to registration of the Common Stock under the Securities Act of
1933, as amended (the "Securities Act") or pursuant to an exemption from
registration under the Securities Act.

Dated:
                                    (Signature must conform to name of holder as
                                    specified on the face of the Warrant)

                                    Address:

<PAGE>
                                    Exhibit B

                         FORM OF TRANSFEROR ENDORSEMENT
                   (To Be Signed Only On Transfer Of Warrant)

         For value received, the undersigned hereby sells, assigns, and
transfers unto the person(s) named below under the heading "Transferees" the
right represented by the within Warrant to purchase the percentage and number of
shares of Common Stock of AMS Health Sciences, Inc. into which the within
Warrant relates specified under the headings "Percentage Transferred" and
"Number Transferred," respectively, opposite the name(s) of such person(s) and
appoints each such person Attorney to transfer its respective right on the books
of AMS Health Sciences, Inc. with full power of substitution in the premises.

                                             Percentage              Number
Transferees           Address               Transferred           Transferred
-----------           -------               -----------           -----------





Dated:
                                    (Signature must conform to name of holder as
                                    specified on the face of the Warrant)

                                    Address:



                                    SIGNED IN THE PRESENCE OF:

                                                (Name)
ACCEPTED AND AGREED:
[TRANSFEREE]


     (Name)